254 related articles for article (PubMed ID: 9607031)
1. Immunogenicity and protective role of three formulations of oral cholera vaccine.
Kalambaheti T; Chaisri U; Srimanote P; Pongponratn E; Chaicumpa W
Vaccine; 1998; 16(2-3):201-7. PubMed ID: 9607031
[TBL] [Abstract][Full Text] [Related]
2. CpG DNA, liposome and refined antigen oral cholera vaccine.
Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers.
Chaicumpa W; Chongsa-nguan M; Kalambaheti T; Wilairatana P; Srimanote P; Makakunkijcharoen Y; Looareesuwan S; Sakolvaree Y
Vaccine; 1998 Apr; 16(7):678-84. PubMed ID: 9562686
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens.
Chaicumpa W; Parairo JR; New RC; Pongponratn E; Ruangkunaporn Y; Tapchaisri P; Chongsa-nguan M
Asian Pac J Allergy Immunol; 1990 Dec; 8(2):87-94. PubMed ID: 2091663
[TBL] [Abstract][Full Text] [Related]
6. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation.
Borde A; Larsson A; Holmgren J; Nygren E
Eur J Pharm Biopharm; 2011 Nov; 79(3):508-18. PubMed ID: 21757004
[TBL] [Abstract][Full Text] [Related]
9. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
Fakoya B; Sit B; Waldor MK
J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of two formulations of oral cholera vaccines in Thai volunteers.
Chongsa-nguan M; Chaicumpa W; Ruangkunaporn Y; Looareesuwan S
Vaccine; 1991 Jan; 9(1):53-9. PubMed ID: 2008802
[TBL] [Abstract][Full Text] [Related]
11. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET
mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076
[TBL] [Abstract][Full Text] [Related]
12. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.
Migasena S; Desakorn V; Suntharasamai P; Pitisuttitham P; Prayurahong B; Supanaranond W; Black RE
Infect Immun; 1989 Jan; 57(1):117-20. PubMed ID: 2909484
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Vibrio cholerae O1 fimbriae in animal and human cholera.
Ehara M; Ichinose Y; Iwami M; Utsunomiya A; Shimodori S; Kangethe SK; Neves BC; Supawat K; Nakamura S
Microbiol Immunol; 1993; 37(9):679-88. PubMed ID: 7505875
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Cryz SJ; Fürer E; Germanier R
Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
[TBL] [Abstract][Full Text] [Related]
16. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
[TBL] [Abstract][Full Text] [Related]
17. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1996 Oct; 14(15):1459-65. PubMed ID: 8994322
[TBL] [Abstract][Full Text] [Related]
18. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
[TBL] [Abstract][Full Text] [Related]
19. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
20. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
